Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

Impact of gonadotropin genetic profile and ovarian reserve on controlled ovarian stimulation: data from prospective cohort of the GENOCS trial

Articolo
Data di Pubblicazione:
2025
Citazione:
Impact of gonadotropin genetic profile and ovarian reserve on controlled ovarian stimulation: data from prospective cohort of the GENOCS trial / Conforti, A.; Santi, D.; Allegra, A.; Mignini Renzini, M.; Marino, A.; Brigante, C.; Iemmello, R.; Vanni, V. S.; Rebecchi, A.; Privitera, L.; Sperduti, S.; Casarini, L.; Carbone, I. F.; Simoni, M.; Alviggi, C.; Papaleo, E.. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 16:(2025), pp. 1-10. [10.3389/fendo.2025.1601803]
Abstract:
Introduction: Several studies indicate that a specific genotype profile could influence ovarian sensitivity to exogenous gonadotropin. However, most of the previous studies were observational and retrospective and thereby more prone to bias. The aim of this study was to evaluate the impact of gonadotropin single nucleotide polymorphisms (SNPs) on the outcomes of in-vitro fertilization (IVF) in infertile patients undergoing their first ovarian stimulation (OS) cycle. Method: A multicenter, longitudinal, prospective, interventional cohort study was carried out in four clinical centers of medically assisted reproduction from August 2016 to November 2018. Only expected normo-responder women, estimated through standardized-computerized antral follicle count (AFC), stimulated with a fixed 150 IU daily dose of recombinant follicle-stimulating hormone (FSH), were included. The study population consisted of infertile normo-gonadotropic patients, aged between 34 and 39, at their first OS, with normal ovarian reserve (AFC between 8 and 16) measured with 3D automated ultrasonography and undergoing standardized OS protocol. Results: One hundred nineteen patients were enrolled, and the following five SNPs were studied (FSHR c.-29G>A, FSHR p.N680S, FSHB c.-211G>T, LHCGR p.S312N, and LHβ “V-LH” p.W8R). Separate and multivariate analysis of investigated polymorphisms did not show any statistical impact on the number of oocytes retrieved. However, adopting an overdominant model, heterozygosis of FSHR p.N680S SNP was associated with significantly lower duration of OS compared with homozygotic women. Considering LHCGR p.S312N polymorphism, N allele carriers required a longer duration of OS in the codominant, dominant, and log-additive models. Multivariate analysis revealed that specific genotype combinations could affect the ovarian sensitivity. A significantly higher follicle-to-oocyte index (FOI) was observed when the S or N allele of both FSHR p.N680S and LHCGR p.S312N were combined (S allele combination: difference 0.18, CI 95% 0.04–0.33, p = 0.011; N allele combination: difference 0.18, CI 95% 0.01–0.34, p = 0.037; N allele combination). Discussion: Based on our results, the combination of specific genetic variants could impact ovarian sensitivity to gonadotropin. This research adds to the controversy in the literature regarding the effect of genetic variants in IVF and ovarian response.
Tipologia CRIS:
Articolo su rivista
Keywords:
ART; genetic variants; IVF/ICSI; ovarian stimulation; pharmacogenomic; polymorphisms
Elenco autori:
Conforti, A.; Santi, D.; Allegra, A.; Mignini Renzini, M.; Marino, A.; Brigante, C.; Iemmello, R.; Vanni, V. S.; Rebecchi, A.; Privitera, L.; Sperduti, S.; Casarini, L.; Carbone, I. F.; Simoni, M.; Alviggi, C.; Papaleo, E.
Autori di Ateneo:
CASARINI Livio
SANTI Daniele
SIMONI Manuela
SPERDUTI SAMANTHA
Link alla scheda completa:
https://iris.unimore.it/handle/11380/1386469
Link al Full Text:
https://iris.unimore.it//retrieve/handle/11380/1386469/920486/fendo-1-1601803.pdf
Pubblicato in:
FRONTIERS IN ENDOCRINOLOGY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0